RESUMO
Prostate, breast and colorectal cancer are the most common tumours in Spain. The aim of the present study was to evaluate the association between adherence to nutrition-based guidelines for cancer prevention and prostate, breast and colorectal cancer, in the MCC-Spain case-control study. A total of 1,718 colorectal, 1,343 breast and 864 prostate cancer cases and 3,431 population-based controls recruited between 2007 and 2012, were included in the present study. The World Cancer Research Fund/American Institute for Cancer Research (WCRC/AICR) score based on six recommendations for cancer prevention (on body fatness, physical activity, foods and drinks that promote weight gain, plant foods, animal foods and alcoholic drinks; score range 0-6) was constructed. We used unconditional logistic regression analysis adjusting for potential confounders. One-point increment in the WCRF/AICR score was associated with 25% (95% CI 19-30%) lower risk of colorectal, and 15% (95% CI 7-22%) lower risk of breast cancer; no association with prostate cancer was detected, except for cases with a Gleason score ≥7 (poorly differentiated/undifferentiated tumours) (OR 0.87, 95% CI 0.76-0.99). These results add to the wealth of evidence indicating that a great proportion of common cancer cases could be avoided by adopting healthy lifestyle habits.
Assuntos
Neoplasias da Mama/epidemiologia , Neoplasias Colorretais/epidemiologia , Terapia Nutricional , Neoplasias da Próstata/epidemiologia , Neoplasias da Mama/dietoterapia , Neoplasias da Mama/patologia , Neoplasias Colorretais/dietoterapia , Neoplasias Colorretais/patologia , Feminino , Humanos , Estilo de Vida , Masculino , Neoplasias da Próstata/dietoterapia , Neoplasias da Próstata/patologia , Fatores de Risco , Espanha/epidemiologiaRESUMO
Fundamento y objetivo: Analizar los efectos de la intervención nutricional con un producto lácteo enriquecido con isoflavonas de soja sobre la calidad de vida y el metabolismo óseo en mujeres posmenopáusicas españolas. Pacientes y método: Estudio aleatorizado, controlado y doble ciego. Un total de 99 mujeres posmenopáusicas fueron distribuidas en el grupo S (n=48) con consumo de un producto lácteo enriquecido con isoflavonas de soja (50mg/día) y en el grupo C (n=51) con consumo de un producto lácteo control durante 12 meses. Se evaluaron parámetros de calidad de vida (escala Cervantes), marcadores de metabolismo óseo y masa ósea estimada mediante ultrasonografía de calcáneo (QUS).Resultados: En conjunto, hubo una mejoría en los dominios menopausia (p=0,015) y sintomatología vasomotora (p<0,001). En el grupo S destacó la valoración de la sintomatología vasomotora (p=0,001) y se diferenció positivamente respecto al grupo C en salud (p=0,019), sexo (p=0,021) y pareja (p=0,002). Se produjo un descenso de fosfatasa ácida tartrato resistente (p<0,001) y osteoprotegerina (p=0,007) y un aumento de los valores de 25-OH-vitamina D (p<0,001), sin diferencias entre grupos. En la evaluación del QUS, se observó un incremento de la densidad mineral ósea estimada en el grupo S (p=0,040), mientras que en el grupo C no se observaron diferencias significativas. Conclusiones: El consumo diario de estos productos lácteos aumenta los niveles de 25-OH-vitamina D y supone un descenso de algunos marcadores del metabolismo óseo. La suplementación adicional con isoflavonas de soja parece mejorar la calidad de vida y la masa ósea en mujeres posmenopáusicas españolas (AU)
Background and objective: To analyze the effects of nutritional intervention with a milk product enriched with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women.Patients and method: We performed a double-blind controlled randomized trial in ninety-nine postmenopausal women. Group S women (n=48) were randomized to consume milk product enriched with soy isoflavone (50mg/day) while group C (n=51) consumed product control for 12 months. Parameters of quality of life (Cervantes scale), markers of bone metabolism and bone mass estimated by ultrasound of the calcaneus (QUS) were evaluated. Results: Overall, there was an improvement in the domains menopause (P=.015) and vasomotor symptoms (P<.001). S group emphasized the assessment of vasomotor symptoms (P=.001) and differed positively from group C in health (P=.019), sex (P=.021) and partner (P=.002). Serum levels TRAP (P<.001) and OPG (P=.007) decreased and concentrations of 25-OH-vitamin D increased (P<.001) without differences between groups. In the assessment of QUS, there was an increase in estimated bone mineral density in group S (P=.040), whereas in group C there were no significant differences. Conclusions: Daily consumption of these milk products increases levels of 25-OH-vitamin D and decreases bone metabolism markers. Additional supplementation with soy isoflavones seems to improve quality of life and bone mass in Spanish postmenopausal women
Assuntos
Humanos , Feminino , Leite de Soja/farmacocinética , Isoflavonas/farmacocinética , Osteoporose Pós-Menopausa/prevenção & controle , Fitoestrógenos/uso terapêutico , Distúrbios do Metabolismo do Cálcio/dietoterapia , Qualidade de VidaRESUMO
BACKGROUND AND OBJECTIVE: To analyze the effects of nutritional intervention with a milk product enriched with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women. PATIENTS AND METHOD: We performed a double-blind controlled randomized trial in ninety-nine postmenopausal women. Group S women (n=48) were randomized to consume milk product enriched with soy isoflavone (50 mg/day) while group C (n=51) consumed product control for 12 months. Parameters of quality of life (Cervantes scale), markers of bone metabolism and bone mass estimated by ultrasound of the calcaneus (QUS) were evaluated. RESULTS: Overall, there was an improvement in the domains menopause (P=.015) and vasomotor symptoms (P<.001). S group emphasized the assessment of vasomotor symptoms (P=.001) and differed positively from group C in health (P=.019), sex (P=.021) and partner (P=.002). Serum levels TRAP (P<.001) and OPG (P=.007) decreased and concentrations of 25-OH-vitamin D increased (P<.001) without differences between groups. In the assessment of QUS, there was an increase in estimated bone mineral density in group S (P=.040), whereas in group C there were no significant differences. CONCLUSIONS: Daily consumption of these milk products increases levels of 25-OH-vitamin D and decreases bone metabolism markers. Additional supplementation with soy isoflavones seems to improve quality of life and bone mass in Spanish postmenopausal women.